Francois-Clement Bidard, MD, PhD

home / authors / francois-clement-bidard-md-phd

Articles

Dr. Bidard on the Importance of Elacestrant in ER+/HER2- Breast Cancer

July 12th 2022

Francois-Clement Bidard, MD, PhD, discusses the importance of elacestrant in estrogen receptor–positive, HER2-negative, advanced or metastatic breast cancer.

Dr. Bidard on the Clinical Utility of Circulating Tumor Cell Count in Breast Cancer

December 6th 2018

Francois-Clement Bidard, MD, PhD, professor, medical oncologist, Institut Curie, discusses the clinical utility of circulating tumor cell count (CTC) in breast cancer at the 2018 San Antonio Breast Cancer Symposium.